2013-08-20 - Male
549060
| Adverse reaction report number | 549060 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2013-08-20 |
| Latest received date | 2013-08-20 |
| Age | N/A |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | Community |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | Product used for unknown indication | ||
| BETA-BLOCKING AGENTS | NOT SPECIFIED | Concomitant | |||||
| ETHANOL | NOT SPECIFIED | Concomitant | |||||
| XANAX | TABLET | Concomitant |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Vision blurred | |